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http://dx.doi.org/10.1016/j.hkjn.201Summary Purpose: It hasbeenreportedthataccelerationplethysmography(APG)that isanonin-
vasive and very simplemethod for the assessment of arterial stiffness. The objectives of the present
study were to evaluate usefulness of APG and to compare the data on blood pressure (BP), serum
biochemistry, and aortic calcification index (ACI) in chronic kidney disease (CKD) patients.
Methods: ACI, systolic BP, diastolic BP, and serumbiochemistry valueswereobtained from35hemo-
dialysis (HD group) patients, 15 peritoneal dialysis (PD group) patients and 20 nondialysis patients
(CKD Stages 1e5; nondialysis group). After APG, the acceleration plethysmogram aging index
(APG-AI) was calculated. Aortic calcification was measured semiquantitatively using computed
tomography (CT) images of the abdominal aorta, and then ACI was calculated.
Results: Phosphate (PO4) and calciumphosphate product (CaPO4) in the HD or PD groups were
significantly higher than those in the nondialysis group. APG-AI and ACI, which are used for evalua-
tion of arteriosclerosis, in HD or PD groupswerehigher comparedwith the nondialysis group. APG-AI
and ACI increased with aging. APG-AI was significantly correlated with ACI.
Conclusion: APG-AI and ACI in the HD and PD groups were more advanced than in the nondialysis
group. Aortic calcification in the HD and PD groups was affected by high levels of P and CaPO4.
There was a significant correlation between APG, a functional evaluation of arteriosclerosis, and
ACI, amorphological evaluation. Therefore, it appears that APGmight provide valuable information
on arteriosclerosis in CKD patients.
背景:對於動脈硬化程度的評估，加速度體積描記法(acceleration plethysmography, APG)是一個
很簡單的非侵入性方法。本研究在慢性腎病(CKD)患者間進行了APG測量，並與血壓(BP)、血清生
化學、及主動脈鈣化指數(ACI)作出比較。ephrology, Department of Internal Medicine, Faculty of Medicine, Juntendo University, 2-1-1, Hongo,
.jp (Y. Tomino).
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CKD患者的動脈硬化發展提供有用的資訊。Figure 1 An example trace of real-time recording. Velocity
plethysmogram (VPG) expresses the first derivative of PTG
(plethysmogram). APG (acceleration plethysmogram) uses the
second derivative of the waveform of the plethysmogram to
stabilize the baseline and to separate components of the
waveform more clearly than VPG. Waveforms of APG: APG
consisted of five waveforms as follows: a waveZ early systolic
positive wave; b waveZ early systolic negative wave; c waveZ
late systolic re-increasing wave; d wave Z late systolic
re-decreasing wave; e wave Z early diastolic positive wave.
APG-AI was calculated as follows: APG-AIZ (becedee)/a.Introduction
Arteriosclerosis is a main underlying cause of cardiovascular
diseases, including coronary heart disease and stroke, and
the leading cause of death in hemodialysis (HD) and peri-
toneal dialysis (PD) patients. It has been reported that
hyperphosphatemia and increased calciumphosphate
product (CaPO4) are closely related to aortic calcification,
which may be implicated in the occurrence of cardiovas-
cular events in HD and PD patients.1,2 Since early detection
and prevention of arteriosclerosis are essential, screening
and monitoring tests are necessary for such patients.
Evaluation of arteriosclerosis is usually determined by
several methods such as pulse pressure,3 pulse wave
velocity (PWV),4 aortic calcification index (ACI) measured
by computed tomography (CT)5 or combinations of these
methods.
Recently, plethysmography (PTG) has been widely used
as a conventional noninvasive method to obtain information
on peripheral circulatory kinetics.6 However, the results of
PTG are difficult to analyze because of major fluctuations
from baseline and waveforms tend to be flat. Acceleration
PTG (APG), the second derivative of PTG, emphasizes an
inflection point in a wave in the same phase as PTG, and
reflects peripheral hemodynamics more accurately than
PTG.6e11 It has been reported that APG, a noninvasive test,
is useful for estimation of risk of chronic heart disease
(CHD) in the general population.11 It has also been sug-
gested that it could be used as an indicator of peripheral
circulatory dynamics in patients with arteriosclerosis.
In this study, APG was performed concurrently with ACI5
measurement by abdominal CT and blood tests in HD and PD
patients, who might have more advanced arteriosclerosis,
and nondialysis patients to look into the correlation among
these methods and to evaluate the value and usefulness of
APG as a measurement method of arteriosclerosis.
Patients and methods
Patients
Patients were randomly selected and all gave informed
consent to participate in this clinical study. Patients were
classified according to estimated glomerular filtration rate
(eGFR) as Stage 1 to 5 according to the Kidney Disease
Outcomes Quality Initiative.12 Subjects were consecutive
outpatients at the Juntendo University Hospital andShinjuku Minamiguchi Ekimae Clinic, Tokyo, Japan. Patients
with chronic kidney disease (CKD) Stage 5D were on regular
HD therapy (HD group; duration of HD 82.6  13.0 months),
or PD therapy (PD group; duration of PD 50.3  8.3 months).
The HD group consisted of 22 men and 13 women aged from
27 to 86 years (59.8  2.4 years). The PD group included 9
men and 6 women aged from 33 to 66 years (55.3  2.4
years). The nondialysis group (CKD Stages 1e5) included 11
men and nine women aged from 26 to 79 years (57.8  3.7
years), with four patients at each CKD stage. Systolic (SBP)
and diastolic blood pressure (DBP) were measured with
a mercury sphygmomanometer with the cuff applied to the
arm in the sitting position before BP measurement. In HD
group, BP was measured before starting at the HD session.
In PD and nondialysis groups, BP was measured at routine
visits to the outpatients clinic. Biochemical analyses
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82.6  13.0 50.3  8.3 e
SBP (mmHg) 143.3  3.4 135.7  3.1 138.5  3.6
DBP (mmHg) 78.1  2.4 76.1  3.0 75.1  3.4
TC (mg/dL) 173.6  3.7 175.3  6.4 189.3  16.6
TG (mg/dL) 131.3  10.4 148.8  18.5 126.1  16.6
HDLC (mg/dL) 48.5  2.3 45.1  4.1 50.4  2.7
HLDLC (mg/dL) 97.0  3.5 99.9  6.9 110.6  5.4
50 J. Inuma et al.included serum Ca, PO4, CaPO4, total cholesterol (TC),
high-density lipoprotein cholesterol (HDL-C), low-density
lipoprotein cholesterol (LDL-C), and triglyceride (TG).
Recording of APG
A DYNA PULSE SDP-100 (Fukuda Denshi, Tokyo, Japan) was
used to record the APG, which is a double differentiation of
the ordinary plethysmogram. After resting for several
minutes, the hand was positioned at the height of the heart
in the sitting position. The APG waves were classified as
follows; early systolic positive waves (a waves), early
systolic negative waves (b waves), re-ascending meso-
systolic waves (c waves), postsystolic negative waves (d
waves) and protodiastolic positive waves (e waves)7
(Fig. 1).
The APG aging index (APG-AI) was defined as follows6:
APG-AIZ ðb  c  d  eÞ=a
APG was recorded for each subject was measured at the
second finger of the right hand for PD and nondialysis
patients. In the HD group, APG was recorded on the second
finger of the hand without an arteriovenous (A-V) fistula at




























Figure 2 The level of Ca, PO4, and CaPO4 in CKD patients. PO4
nondialysis group (p < 0.05, respectively). There were no differenMeasurement and calculation of ACI
Each patient underwent a CT abdominal scan. Calcification
of the abdominal aorta above its bifurcation was evaluated
semiquantitatively in 10 CT slices at 1 cm intervals by
a slight modification of the technique previously reported.5
In brief, the cross-section of the abdominal aorta on each
slice was divided into 12 sectors, and the number of sectors
with calcification was counted in each slice. The values
thus obtained for 10 slices were totaled. The totals were
also divided by 10 (the number of slices inspected) and
multiplied by 100 to express the result as a percentage. The
aortic calcification index (ACI) was calculated for each
patient and was used as the indicator of the extent of aortic
calcification.Statistical analysis
Data are expressed as mean  SE. Analyses were performed
using a statistical program Stat View version 5.0 (SAS
Institute, Cary, NC, USA). ManneWhiney U test was used for
comparison among the HD, PD and nondialysis groups.
Correlations among them were determined using Pearson’s
test. A p-value of <0.05 denoted a statistically significant
difference.Results
Clinical characteristics of HD, PD and nondialysis
groups
Table 1 shows the clinical characteristics of the HD, PD and
nondialysis groups. There were no significant differences in
age, gender, SBP, DBP, TC, TG, HDLC and LDLC among these
groups. No significant difference with dialysis duration was
observed between HD group and PD group. As shown in
Fig. 2, the level of PO4 and CaPO4 in the HD and PD groups
was significantly higher than that in the nondialysis group
(5.1  0.2, 5.2  0.3 vs. 4.0  0.2, respectively, p < 0.05;
45.5  2.0, 47.2  2.7 vs. 37.2  1.5, respectively,




















and CaPO4 were higher in the HD and PD groups than in the
ces in Ca among HD, PD, and nondialysis groups.
Table 2 Scores of APG-AI and ACI.
HD group PD group Nondialysis group
APG-AI 0.007  0.04* 0.024  0.05* 0.21  0.07
ACI (%) 25.5  3.6* 18.4  3.7* 9.4  0.2
*p < 0.05 vs. nondialysis group.
Relationship between APG and ACI in CKD patients 51among the HD, PD and nondialysis groups (9.0  0.1,
9.5  0.2, 9.4  0.2).
Correlation among APG-AI, ACI and age
APG-AI of the hand with an A-V fistula was lower than that
of the hand without an A-V fistula in 25 HD patients (71.4%).
It was suggested that lower APG-AI of the hand with an A-V
fistula was caused by an abnormal peripheral circulatory
system. Consequently, APG was measured at the second
finger of the hand without an A-V fistula in the HD group to
estimate APG correctly.
The APG-AI in the HD and PD groups was significantly
higher than that in the nondialysis group (e0.007  0.04,
e0.024  0.05 vs. e0.21  0.07, respectively, p < 0.05) as
shown in Table 2. The ACI was markedly increased in the HDA
C
Figure 3 Correlation among APG-AI, ACI and age. (A) Relationsh
scores of (B) APG-AI and (C) ACI.and PD groups compared with nondialysis group (25.5  3.6,
18.4  3.7 vs. 9.4  0.2, respectively, p < 0.05) (Table 2).
ACI was correlated with APG-AI (y Z 0.008x  0.227,
r Z 0.57, p < 0.05). Both APG-AI and ACI were also
correlated with age (y Z 24.9x þ 60.0, r Z 0.48, p < 0.05
for APG-AI, y Z 0.33x þ 51.9, r Z 0.44, p < 0.05 for ACI;
Fig. 3).
Discussion
Arteriosclerosis is the most common and critical complica-
tion of CKD, which leads to cardiovascular disease, and
becomes severe with progression of renal dysfunction.13 In
view of the constantly increasing number of dialysis
patients, evaluation of arteriosclerosis and prevention of
disease progression may greatly contribute to improvement
of the vital prognosis of dialysis patients.
At present, ACI is frequently used as a method to eval-
uate arteriosclerosis. However, ACI has a problem in that
patients must bear a considerable burden of radiation
exposure at the time of testing. Recently, APG has attrac-
ted attention as an index to evaluate arteriosclerosis non-
invasively, and an increasing number of the studies have
been carried out on APG.6e11 In view of this background, it
was necessary to investigate APG and ACI, and to determine
the correlation between APG and ACI in CKD patients.B
ip between APG-AI and ACI. Comparison between age and the
52 J. Inuma et al.In the present study, APG-AI and ACI were estimated in
HD, PD and nondialysis groups. It has been reported that
APG-AI was correlated with age.6 In this study, a similar
result was seen. Moreover, there was a significant increase
of APG-AI and ACI in the HD and PD groups compared with
the nondialysis group. These results suggest that there are
vascular lesions such as arteriosclerosis in the HD and PD
groups. It was reported that high levels of TC, LDL-C, and
TG and a low level of HDL-C are risk factors for cardiovas-
cular disease in particular.14e17 In our study, there were no
significant differences in age, gender, SBP, DBP, TC, TG,
HDL-C, and LDL-C among these groups. In end stage kidney
disease, marked arterial calcification is observed and
medial types are increased according to calcium-phosphate
disorders.18,19 In this study, PO4 and CaPO4 in the HD and
PD groups were significantly increased compared with those
in the nondialysis group. High serum Ca and PO4 concen-
trations appeared to be associated with more extensive
aortic and coronary calcification in prevalent HD patients.20
Elevations in PO4, Ca, and CaPO4 induced by therapy with
calcium containing phosphorus binder in HD patients were
thought to be associated with accelerated vascular calcifi-
cation.20 In a rat model of kidney failure, hyper-
phosphatemia induced by a high-phosphorus diet produced
cardiac fibrosis and arterial wall thickening19 Raising PO4
concentrations in cell culture media of vascular smooth
muscle cells led to deposition of hydroxyapatite and
induced a phenotypic switch into osteoblast-like cells, both
of which were dependent on a rise in the intracellular
phosphate concentration.21 This might be a factor in arte-
riosclerosis that caused an increase of APG-AI and ACI in the
HD and PD groups.
It was suggested that APG could be an alternative
method of ACI for evaluating the development of arterio-
sclerosis in a noninvasive way. However, APG is a functional
index based on vascular distensibility and the degree of
calcification,6e11 while ACI is an index that reflects vascular
morphology,5 each of these indices evaluates arterioscle-
rosis from a different perspective. In this study, the
consistency in the results obtained from these evaluation
methods of arteriosclerosis with different perspectives
suggests that APG is a significant method for use in further
clinical studies on arteriosclerosis in the future. Further-
more, APG is a suitable evaluation method of arterioscle-
rosis for the blood vessels of end stage kidney disease
patients with decreased distensibility due to calcification in
the middle coat of the artery occurring in the process of
differentiation of vascular smooth muscle cells into
osteoblast-like cells by calcium-phosphate disorders.21 The
clinical significance of APG in CKD patients remains uncer-
tain. It will be necessary to examine more patients and to
compare the findings by APG in the future. We hope that
APG will become more significant as a method for evalu-
ating arteriosclerosis.Conclusion
In CKD patients, a significant correlation was observed
between APG (a functional evaluation method of arterio-
sclerosis) and ACI (a morphological evaluation method). Itappears that APG might be useful for evaluation of the
arteriosclerosis.
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